Concepedia

Author

Beate Schmitz

University of Cologne

Also Known As

B Schmitz, B. SCHMITZ, B. Schmitz, BEATE SCHMITZ, Beate Schmitz

57

Publications

1.3K

Citations

17

H-Index

51

Concepts

All Affiliations

University of CologneBiofrontera (Germany)University of WuppertalWitten/Herdecke UniversityMahlo (Germany)
BS

About

Beate Schmitz is an author at University of Cologne specializing in medicine, cell biology, and biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

11

400

2

Natural Sciences

2

2

38

3

Health Sciences

1

1

15

4

Allergy

1

1

15

5

Anatomy

1

1

123

Beate Schmitz

×

26

Publications

1.2K

Citations

17

H-Index

YearCitations

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo

Thomas Dirschka, Peter Radny, R. Dominicus,

British Journal of Dermatology

2011

178

Magnetic activated cell sorting (MACS) — a new immunomagnetic method for megakaryocytic cell isolation: Comparison of different separation techniques

Beate Schmitz, Andreas Radbruch, T. Kümmel,

European Journal Of Haematology

1994

137

Neurulation in the anterior trunk region of the zebrafish Brachydanio rerio

Beate Schmitz, Cyrus Papan, Jos� A. Campos-Ortega

Development Genes and Evolution

1993

123

Long‐term (6 and 12 months) follow‐up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF‐200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis

Thomas Dirschka, Peter Radny, R. Dominicus,

British Journal of Dermatology

2012

98

A randomized, double‐blind, phase <scp>III</scp> , multicentre study to evaluate the safety and efficacy of <scp>BF</scp> ‐200 <scp>ALA</scp> (Ameluz <sup>®</sup> ) vs. placebo in the field‐directed treatment of mild‐to‐moderate actinic keratosis with photodynamic therapy (PDT) when using the <scp>BF</scp> ‐Rhodo <scp>LED</scp> <sup>®</sup> lamp

Uwe Reinhold, Thomas Dirschka, Rolf Ostendorf,

British Journal of Dermatology

2016

89

Secretion of cytokines (interleukins-1 alpha, -3, and -6 and granulocyte-macrophage colony-stimulating factor) by normal human bone marrow megakaryocytes

Claudia Wickenhauser, Johann Lorenzen, J. Thiele,

Blood

1995

79

Sgk1, a cell survival response in neurodegenerative diseases

Bodo Schoenebeck, Verian Bader, Xin‐Ran Zhu,

Molecular and Cellular Neuroscience

2005

79

A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy

C.A. Morton, R. Dominicus, Peter Radny,

British Journal of Dermatology

2018

70

A randomized, intraindividual, non‐inferiority, Phase <scp>III</scp> study comparing daylight photodynamic therapy with <scp>BF</scp>‐200 <scp>ALA</scp> gel and <scp>MAL</scp> cream for the treatment of actinic keratosis

Thomas Dirschka, S. Ekanayake‐Bohlig, R. Dominicus,

Journal of the European Academy of Dermatology and Venereology

2018

58

Dorso-ventral polarity of the zebrafish embryo is distinguishable prior to the onset of gastrulation

Beate Schmitz, Jos� A. Campos-Ortega

Development Genes and Evolution

1994

40

Page 1